(+)-(3AR,4R,5R,6AS)-六氢-5-羟基-4-[(1E,3R)-3-羟基-5-苯基-1-戊烯基]-2H-环戊并[B]呋喃-2-酮

(+)-(3AR,4R,5R,6AS)-六氢-5-羟基-4-[(1E,3R)-3-羟基-5-苯基-1-戊烯基]-2H-环戊并[B]呋喃-2-酮性质、用途与生产工艺

(+)-(3AR,4R,5R,6AS)-六氢-5-羟基-4-[(1E,3R)-3-羟基-5-苯基-1-戊烯基]-2H-环戊并[B]呋喃-2-酮 上下游产品信息

上游原料

下游产品

(+)-(3AR,4R,5R,6AS)-六氢-5-羟基-4-[(1E,3R)-3-羟基-5-苯基-1-戊烯基]-2H-环戊并[B]呋喃-2-酮 生产厂家

41639-74-1, (+)-(3AR,4R,5R,6AS)-六氢-5-羟基-4-[(1E,3R)-3-羟基-5-苯基-1-戊烯基]-2H-环戊并[B]呋喃-2-酮 相关搜索:

• 原料药中间体
• 比马前列素
• 中间体
• 贝美前列素杂质9
• 拉坦前列素关键中间体
• (3AR,4R,5R,6AS)-5-羟基-4-((S,E)-3-羟基-5-苯戊-1-烯-1-基)六氢-2H-环戊烷[B]呋喃-2-酮
• 比马前列素杂质2
• 比马前列素杂质19
• 双环磷素杂质2
• (3AR,4R,5R,6AS)-5-羟基-4-[(S,E)-3-羟基-5-苯基戊-1-烯-1-基]六氢-2H-环戊烯并[B]呋喃-2-酮
• 2H-环戊并[B]呋喃-2-酮,六氢-5-羟基-4-[(1E,3S)-3-羟基-5苯基-1-戊烯-1-基]-,(3AR,4R,5R,6AS)-(...)
• 前列腺素中间体41639-74-1,含量98%41639-74-1
• (+)-(3AR,4R,5R,6AS)-六氢-5-羟基-4-[(1E,3R)-3-羟基-5-苯基-1-戊烯基]-2H-环戊并[B]呋喃-2-酮
• 41639-74-1
• (3aR,4R,5R,6aS)-5-hydroxy-4-((S,E)-3-hydroxy-5-phenylpent-1-enyl)hexahydro-2H-cyclopenta[b]furan-2-one
• (+)-(3Ar,4R,5R,6as)-hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-5-phenyl-1-pentenyl]-2H-cyclopenta[b]furan-2-one
• (3aR,4R,5R,6aS)-5-hydroxy-4-[(3S)-3-hydroxy-5-phenylpent-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-one
• Bimatoprost Impurity 19
• Lactonediol B
• (3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]-2H-cyclopenta[b]furan-2-one
• (3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-[(1E,3S)-5-phenyl-3-hydroxy-(1E)-pentenyl]-2H-cyclopentane [β] furan-2-one
• Latanprost
• Bimaprost
• Lactondiol B
• (3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]-2H-cyclopenta[b]furan-2-one
• 2H-Cyclopenta[b]furan-2-one,hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]-,(3aR,4R,5R,6aS)-
• (3aR,4R,5R,6aS)-5-Hydroxy-4-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one
• BP-2 (LT-EDI)(Bimaprost、Latanprost)
• BP-2 (LT-EDI)
• (+)-(3aR,4R,5r,6aS)-Hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-5-phenyl-1-pentenyl]-2H-cyclopenta[b]furan-2-one
• HYDRIDE-L